Risk Factors for Nursing Home Placement in Cholinesterase Inhibitor Treated Naturalistic Alzheimer Patients.

Research output: Contribution to conferencePoster

59 Downloads (Pure)

Abstract

Aims: To analyse which factors influence nursing home placement (NHP) and time until NHP in long-term cholinesterase inhibitor treated patients with Alzheimer’s disease (AD). Methods: The Swedish Alzheimer Treatment Study (SATS) is an open, on-going, non-randomized, multicentre study in a routine clinical setting. Patients with the diagnosis of AD, living at home at the time of inclusion, receive treatment with donepezil, rivastigmine or galantamine. They are assessed with MMSE, ADAS-cog, IADL and PSMS at baseline and every 6 months over the course of 3 years. The first 883 subjects that had the opportunity to complete the full study were investigated concerning NHP; 210 of these patients were admitted to nursing homes. The following risk factors for the event NHP (Chi-square and T-tests) and the time until NHP (Cox regression) were investigated: gender, APOE e4-carrier, living alone or with spouse, education level, age, illness duration, cognitive and functional level at baseline and decline in cognition and function prior to NHP. Results: Females (p=0.002), patients living alone (p<0.001), older age (p=0.002), longer illness duration (p=0.004) and lower cognitive and functional status at baseline (p<0.001) are risk factors for admission to a nursing home. The distribution of time until NHP was significantly affected by gender (p=0.048), living alone (p<0.001) and MMSE and IADL score at baseline (p<0.001). Conclusions: Female gender, patients living alone and lower cognitive or functional ability at baseline demonstrated larger risk of early NHP. Cognitive or functional decline prior to NHP did not influence time until NHP.
Original languageEnglish
Publication statusPublished - 2009
Event9th International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD) - Prague, Czech Republic
Duration: 2009 Mar 112009 Mar 15

Conference

Conference9th International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD)
Country/TerritoryCzech Republic
CityPrague
Period2009/03/112009/03/15

Subject classification (UKÄ)

  • Neurology

Fingerprint

Dive into the research topics of 'Risk Factors for Nursing Home Placement in Cholinesterase Inhibitor Treated Naturalistic Alzheimer Patients.'. Together they form a unique fingerprint.

Cite this